Home LiteratureArticle Details
PMID: 23861892 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Atg4b-dependent autophagic flux alleviates Huntington's disease progression.

PloS one ·Vol. 8 ·No. 7 ·2013-00-00 ·Pages e68357

Proenca CC, Stoehr N, Bernhard M, Seger S, Genoud C, Roscic A, Paganetti P, Liu S, Murphy LO, Kuhn R, Bouwmeester T, Galimberti I

Abstract

The accumulation of aggregated mutant huntingtin (mHtt) inclusion bodies is involved in Huntigton's disease (HD) progression. Medium sized-spiny neurons (MSNs) in the corpus striatum are highly vulnerable to mHtt aggregate accumulation and degeneration, but the mechanisms and pathways involved remain elusive. Here we have developed a new model to study MSNs degeneration in the context of HD. We produced organotypic cortico-striatal slice cultures (CStS) from HD transgenic mice mimicking specific features of HD progression. We then show that induction of autophagy using catalytic inhibitors of mTOR prevents MSNs degeneration in HD CStS. Furthermore, disrupting autophagic flux by overexpressing Atg4b in neurons and slice cultures, accelerated mHtt aggregation and neuronal death, suggesting that Atg4b-dependent autophagic flux influences HD progression. Under these circumstances induction of autophagy using catalytic inhibitors of mTOR was inefficient and did not affect mHtt aggregate accumulation and toxicity, indicating that mTOR inhibition alleviates HD progression by inducing Atg4b-dependent autophagic flux. These results establish modulators of Atg4b-dependent autophagic flux as new potential targets in the treatment of HD.

MeSH Terms
Animals Autophagy/drug effects Autophagy-Related Proteins Biocatalysis/drug effects Cerebral Cortex/drug effects,pathology Cysteine Endopeptidases/metabolism Disease Models, Animal Disease Progression Huntingtin Protein Huntington Disease/complications,metabolism,pathology Morpholines/pharmacology Neostriatum/drug effects,pathology Nerve Degeneration/complications,pathology Nerve Tissue Proteins/metabolism Neurons/drug effects,metabolism,pathology Nuclear Proteins/metabolism Phenotype TOR Serine-Threonine Kinases/antagonists & inhibitors,metabolism
Chemicals
Autophagy-Related Proteins Htt protein, mouse Huntingtin Protein Morpholines Nerve Tissue Proteins Nuclear Proteins (5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol TOR Serine-Threonine Kinases Atg4b protein, mouse Cysteine Endopeptidases
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Proenca Catia C
Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Stoehr Natacha
Bernhard Mario
Seger Shanon
Genoud Christel
Roscic Ana
Paganetti Paolo
Liu Shanming
Murphy Leon O
Kuhn Rainer
Bouwmeester Tewis
Galimberti Ivan
References (45)
45 references, click to expand
  1. Unfolding the role of protein misfolding in neurodegenerative diseases.
    Nat Rev Neurosci. 2003 Jan;4(1):49-60 PMID: 12511861
  2. Huntington's disease: clinical characteristics, pathogenesis and therapies.
    Drugs Today (Barc). 2007 Feb;43(2):97-116 PMID: 17353947
  3. Autophagy and aging.
    Cell. 2011 Sep 2;146(5):682-95 PMID: 21884931
  4. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
    J Neurophysiol. 2001 Dec;86(6):2667-77 PMID: 11731527
  5. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?
    Autophagy. 2008 Oct;4(7):849-50 PMID: 18758232
  6. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Lancet Neurol. 2012 Jan;11(1):42-53 PMID: 22137354
  7. A simple method for organotypic cultures of nervous tissue.
    J Neurosci Methods. 1991 Apr;37(2):173-82 PMID: 1715499
  8. EphA4 signaling in juveniles establishes topographic specificity of structural plasticity in the hippocampus.
    Neuron. 2010 Mar 11;65(5):627-42 PMID: 20223199
  9. Staining protocol for organotypic hippocampal slice cultures.
    Nat Protoc. 2006;1(5):2452-6 PMID: 17406491
  10. Autophagy gone awry in neurodegenerative diseases.
    Nat Neurosci. 2010 Jul;13(7):805-11 PMID: 20581817
  11. Huntington disease.
    J Neuropathol Exp Neurol. 1998 May;57(5):369-84 PMID: 9596408
  12. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.
    Nat Neurosci. 2010 May;13(5):567-76 PMID: 20383138
  13. Atg4B(C74A) hampers autophagosome closure: a useful protein for inhibiting autophagy.
    Autophagy. 2009 Jan;5(1):88-9 PMID: 19104152
  14. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease.
    J Neurosci. 2008 Jul 2;28(27):6926-37 PMID: 18596167
  15. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    J Neurochem. 2008 Feb;104(3):846-58 PMID: 17986219
  16. Studies on brain biopsies of patients with Huntington's chorea.
    J Neuropathol Exp Neurol. 1974 Apr;33(2):308-32 PMID: 4150800
  17. Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.
    Eur J Neurosci. 2013 Feb;37(3):429-40 PMID: 23167744
  18. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications.
    Trends Neurosci. 2010 Dec;33(12):541-9 PMID: 20947179
  19. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    J Neurosci. 2002 May 1;22(9):3473-83 PMID: 11978824
  20. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Cell. 1997 Aug 8;90(3):537-48 PMID: 9267033
  21. Autophagy fights disease through cellular self-digestion.
    Nature. 2008 Feb 28;451(7182):1069-75 PMID: 18305538
  22. Quantitative visualization of autophagy induction by mTOR inhibitors.
    Methods Mol Biol. 2012;821:239-50 PMID: 22125069
  23. Lentiviral-mediated gene transfer to model triplet repeat disorders.
    Methods Mol Biol. 2004;277:199-213 PMID: 15201458
  24. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43.
    Electrophoresis. 1997 Mar-Apr;18(3-4):527-32 PMID: 9150936
  25. Long-term rearrangements of hippocampal mossy fiber terminal connectivity in the adult regulated by experience.
    Neuron. 2006 Jun 1;50(5):749-63 PMID: 16731513
  26. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
    Nat Genet. 2004 Jun;36(6):585-95 PMID: 15146184
  27. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Brain. 1997 Mar;120 ( Pt 3):503-14 PMID: 9126061
  28. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.
    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8093-7 PMID: 10869421
  29. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors.
    EMBO J. 1990 Nov;9(11):3545-50 PMID: 2170117
  30. Relieving autophagy and 4EBP1 from rapamycin resistance.
    Mol Cell Biol. 2011 Jul;31(14):2867-76 PMID: 21576371
  31. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.
    Hum Mol Genet. 2002 May 1;11(9):1107-17 PMID: 11978769
  32. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure.
    Mol Biol Cell. 2008 Nov;19(11):4651-9 PMID: 18768752
  33. Rodent genetic models of Huntington disease.
    Neurobiol Dis. 2008 Oct;32(1):1-9 PMID: 18638556
  34. Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model.
    J Neurochem. 2011 Oct;119(2):398-407 PMID: 21854390
  35. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases.
    J Biol Chem. 2010 Apr 9;285(15):11061-7 PMID: 20147746
  36. mTOR regulation of autophagy.
    FEBS Lett. 2010 Apr 2;584(7):1287-95 PMID: 20083114
  37. Protein aggregation and neurodegenerative disease.
    Nat Med. 2004 Jul;10 Suppl:S10-7 PMID: 15272267
  38. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.
    Methods Enzymol. 2009;453:83-110 PMID: 19216903
  39. Huntington's disease.
    Lancet. 2007 Jan 20;369(9557):218-28 PMID: 17240289
  40. Canonical and non-canonical autophagy: variations on a common theme of self-eating?
    Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12 PMID: 22166994
  41. Preparation of organotypic hippocampal slice cultures for long-term live imaging.
    Nat Protoc. 2006;1(3):1165-71 PMID: 17406399
  42. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
    Mol Neurodegener. 2010 Jun 22;5:26 PMID: 20569486
  43. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
    Mol Aspects Med. 2006 Oct-Dec;27(5-6):520-7 PMID: 16973207
  44. AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks.
    Nat Neurosci. 2003 May;6(5):491-500 PMID: 12692557
  45. A block of autophagy in lysosomal storage disorders.
    Hum Mol Genet. 2008 Jan 1;17(1):119-29 PMID: 17913701
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2013-00-00
Epub
2013-00-08
Pages
e68357
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3704647
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com